These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28549679)

  • 1. One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan.
    Patel H; Patel P; Modi N; Shah S; Ghoghari A; Variya B; Laddha R; Baradia D; Dobaria N; Mehta P; Srinivas NR
    Eur J Pharm Sci; 2017 Aug; 106():87-93. PubMed ID: 28549679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
    Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
    Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
    Kim YK; Shin KH; Alderman J; Yu KS; Jang IJ; Lee S
    Drug Des Devel Ther; 2018; 12():331-337. PubMed ID: 29497279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and Application.
    Srinivas NR; Syed M
    J Pain Palliat Care Pharmacother; 2016; 30(1):13-24. PubMed ID: 26865407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain.
    Khan T; Ranjan R; Dogra Y; Pandya SM; Shafi H; Singh SK; Yadav PN; Misra A
    Mol Pharm; 2016 Sep; 13(9):3234-40. PubMed ID: 27518323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetic drug-drug interaction potential of eletriptan between oral and subcutaneous routes.
    Patel H; Desai N; Patel P; Modi N; Soni K; Dobaria N; Srinivas NR
    Xenobiotica; 2019 Oct; 49(10):1202-1208. PubMed ID: 30588869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.
    Zhou W; Li J; Birmingham B; Xu H; Lillieborg S; Zhou D; Al-Huniti N
    J Clin Pharmacol; 2017 Oct; 57(10):1258-1267. PubMed ID: 28581633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine.
    Steiner TJ; Diener HC; MacGregor EA; Schoenen J; Muirheads N; Sikes CR
    Cephalalgia; 2003 Dec; 23(10):942-52. PubMed ID: 14984226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.
    Dalpiaz A; Marchetti N; Cavazzini A; Pasti L; Velaga S; Gavini E; Beggiato S; Ferraro L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():72-8. PubMed ID: 22743338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ; Chen S; Reidenbach F; Rapoport AM
    Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
    Yu C; Gu P; Zhang W; Cai C; He H; Tang X
    Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray.
    Nguyen J; Lewis H; Queja A; Diep AN; Hochart G; Ameri M
    J Pharm Sci; 2018 Aug; 107(8):2192-2197. PubMed ID: 29772224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal zolmitriptan.
    Gawel M; Worthington I
    Expert Opin Pharmacother; 2005 Jun; 6(6):1019-24. PubMed ID: 15952929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of zolmitriptan and its primary metabolite, n-desmethy-zolmitriptan, in rat plasma by LC-MS-MS.
    Liu J; Zhou X
    J Chromatogr Sci; 2013 Jan; 51(1):59-64. PubMed ID: 22722326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.